Ovid Therapeutics Inc. (OVID): Price and Financial Metrics

Ovid Therapeutics Inc. (OVID)

Today's Latest Price: $7.47 USD

0.34 (-4.35%)

Updated Jul 10 4:00pm

Add OVID to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 338 in Biotech

See all "A" rated Strong Buy stocks

OVID Daily Price Range
OVID 52-Week Price Range

OVID Stock Price Chart Technical Analysis Charts

OVID Price/Volume Stats

Current price $7.47 52-week high $9.40
Prev. close $7.81 52-week low $1.74
Day low $7.41 Volume 594,067
Day high $7.92 Avg. volume 1,003,921
50-day MA $5.65 Dividend yield N/A
200-day MA $3.86 Market Cap 409.01M

Ovid Therapeutics Inc. (OVID) Company Bio

Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company was founded in 2014 and is based in New York City, New York.

OVID Latest News Stream

Event/TimeNews Detail
Loading, please wait...

OVID Latest Social Stream

Loading social stream, please wait...

View Full OVID Social Stream

Latest OVID News From Around the Web

Below are the latest news stories about Ovid Therapeutics Inc that investors may wish to consider to help them evaluate OVID as an investment opportunity.

Is Ovid Therapeutics Inc. (OVID) Going to Burn These Hedge Funds?

How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies. However, an easier way is to look at the stocks that smart money investors are collectively bullish on. Hedge funds and other institutional investors usually invest large amounts of […]

Yahoo | July 9, 2020

Ovid Therapeutics Added to Russell 2000® and Russell 3000® Indexes

NEW YORK, June 29, 2020 -- Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company committed to developing medicines that transform the lives of people with rare.

Yahoo | June 29, 2020

Ovid Therapeutics (OVID) Jumps: Stock Rises 12.4%

Ovid Therapeutics (OVID) saw a big move last session, as its shares jumped more than 12% on the day, amid huge volumes.

Yahoo | June 25, 2020

Implied Volatility Surging for Ovid Therapeutics (OVID) Stock Options

Investors need to pay close attention to Ovid Therapeutics (OVID) stock based on the movements in the options market lately.

Yahoo | June 22, 2020

Ovid nabs Rare Pediatric Disease Designation for OV101 for Angelman Syndrome

The FDA has granted Rare Pediatric Disease Designation to Ovid Therapeutics' (OVID) OV101 (gaboxadol) for the treatment of Angelman syndrome, a rare genetic condition characterized by a variety of signs and symptoms, including delayed development, intellectual disability, speech impairment, problems with movement and balance, seizures, sleep disorders and anxiety.Rare Pediatric...

Seeking Alpha | June 19, 2020

Read More 'OVID' Stories Here

OVID Price Returns

1-mo 42.29%
3-mo 137.14%
6-mo 107.50%
1-year 191.80%
3-year -19.59%
5-year N/A
YTD 80.00%
2019 71.49%
2018 -75.48%
2017 N/A
2016 N/A
2015 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.7009 seconds.